Skip to main content

Table 2 Characteristics of participants in the study

From: Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials

Family number Parent interviewed Child/young person’s age Child/young person’s JIA status (reported by clinician) Treatments experienced by the child/young personb
Tablets IV IM IACI
1 a Mo, Fa 11–13 Flare
2 Mo 5–7 Flare   
3 a Mo 14–16 Flare  
4c Mo, Fa 1–4, 5–7 Diagnosis, Flare   
5 Mo 1–4 Diagnosis    
6 Mo 5–7 Diagnosis   
7 Mo, Fa 1–4 Diagnosis    
8 a Mo, Fa 8–10 Flare   
9 a Mo 11–13 Diagnosis    
10 a Mo 14–16 Flare
11 a Mo 8–10 Flare   
12 a Mo 11–13 Diagnosis   
13 a Mo 14–16 Flare    
14 a Mo 14–16 Flare   
15 Fa 14–16 Flare   
  1. Mo = Mother, Fa = Father, Tablets = Oral prednisolone, IV = Intravenous methylprednisolone, IM = Intra-muscular injection, IACI = Intra-articular injection(s). JIA status as reported by clinician
  2. aFamilies where the child/young person was also interviewed, bReported by parents, cFamily with two children with JIA